Accessibility Menu
Iradimed Corporation Stock Quote

Iradimed Corporation (NASDAQ: IRMD)

$104.86
(9.3%)
+8.89
Price as of February 10, 2026, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$104.86
Daily Change
(9.3%) +$8.89
Day's Range
$99.57 - $107.99
Previous Close
$104.86
Open
$99.57
Beta
0.90
Volume
7,270
Average Volume
77,124
Market Cap
$1.3B
Market Cap / Employee
$105.15M
52wk Range
$47.23 - $107.99
Revenue
N/A
Gross Margin
0.77%
Dividend Yield
0.64%
EPS
$1.75
CAPs Rating
N/A
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Iradimed Corporation Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
IRMD+77%+362.34%+35.83%+1,062%
S&P+14.43%+77.25%+12.13%+250%

Iradimed Corporation Company Info

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

News & Analysis

Financial Health

General

Q4 2025YOY Change
Revenue$22.69M17.0%
Gross Profit$17.03M15.4%
Gross Margin75.06%-1.1%
Market Cap$1.24B78.5%
Market Cap / Employee$7.73M0.0%
Employees1600.0%
Net Income$6.44M25.2%
EBITDA$7.71M28.6%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$51.16M-2.1%
Accounts Receivable$13.86M33.7%
Inventory11.74.3%

Liabilities

Q4 2025YOY Change
Long Term Debt$0.00K-100.0%
Short Term Debt$0.00K-100.0%

Ratios

Q4 2025YOY Change
Return On Assets21.71%1.5%
Return On Invested Capital15.47%1.1%

Cash Flow

Q3 2025YOY Change
Free Cash Flow$5.85M10.2%
Operating Free Cash Flow$6.99M-23.4%

Valuation

MetricQ1 2025Q2 2025Q3 2025Q4 2025YoY Change
Price to Earnings33.9337.0943.1155.6252.25%
Price to Book7.648.4010.0012.5851.43%
Price to Sales8.969.8911.3714.9455.34%
Price to Tangible Book Value7.938.7110.3713.0351.37%
Price to Free Cash Flow TTM178.7499.89126.16143.8134.87%
Enterprise Value to EBITDA110.71102.13118.96155.8543.20%
Free Cash Flow Yield0.6%1.0%0.8%0.7%-25.86%
Return on Equity23.8%23.7%23.3%24.8%1.93%
Total Debt$59.22K$0.00K$0.00K$0.00K-

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.